Your browser doesn't support javascript.
loading
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Facchinetti, Francesco; Mazzaschi, Giulia; Barbieri, Fausto; Passiglia, Francesco; Mazzoni, Francesca; Berardi, Rossana; Proto, Claudia; Cecere, Fabiana Letizia; Pilotto, Sara; Scotti, Vieri; Rossi, Sabrina; Del Conte, Alessandro; Vita, Emanuele; Bennati, Chiara; Ardizzoni, Andrea; Cerea, Giulio; Migliorino, Maria Rita; Sala, Elisa; Camerini, Andrea; Bearz, Alessandra; De Carlo, Elisa; Zanelli, Francesca; Guaitoli, Giorgia; Garassino, Marina Chiara; Ciccone, Lucia Pia; Sartori, Giulia; Toschi, Luca; Dall'Olio, Filippo Gustavo; Landi, Lorenza; Pizzutilo, Elio Gregory; Bartoli, Gabriele; Baldessari, Cinzia; Novello, Silvia; Bria, Emilio; Cortinovis, Diego Luigi; Rossi, Giulio; Rossi, Antonio; Banna, Giuseppe Luigi; Camisa, Roberta; Di Maio, Massimo; Tiseo, Marcello.
Affiliation
  • Facchinetti F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, 94800, Villejuif, France. Electronic address: francescofacchietti2@gmail.com.
  • Mazzaschi G; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Barbieri F; Division of Medical Oncology, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy.
  • Passiglia F; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.
  • Mazzoni F; Medical Oncology Unit, Department of Oncology, Careggi University Hospital, Firenze, Italy.
  • Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Proto C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Cecere FL; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pilotto S; Section of Medical Oncology, Department of Medicine, University of Verona, Verona, Italy.
  • Scotti V; Radiation Therapy Unit, Department of Oncology, Careggi University Hospital, Firenze, Italy.
  • Rossi S; Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano, Milan, Italy.
  • Del Conte A; Medical Oncology and Immuno-Related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Vita E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Università Cattolica Del Sacro Cuore, Rome, Italy.
  • Bennati C; Onco-Hematology Department, S Maria Delle Croci Hospital Ravenna, Italy.
  • Ardizzoni A; Department of Oncology, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy.
  • Cerea G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Migliorino MR; Pneumologia Oncologica, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
  • Sala E; Oncology Unit, Ospedale S. Gerardo, Monza, Italy.
  • Camerini A; Medical Oncology, Azienda USL Toscana Nord-ovest, Ospedale Versilia, Italy.
  • Bearz A; Medical Oncology and Immuno-Related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • De Carlo E; Medical Oncology and Immuno-Related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Zanelli F; Oncology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Guaitoli G; Division of Medical Oncology, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy.
  • Garassino MC; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Ciccone LP; Radiation Therapy Unit, Department of Oncology, Careggi University Hospital, Firenze, Italy.
  • Sartori G; Section of Medical Oncology, Department of Medicine, University of Verona, Verona, Italy.
  • Toschi L; Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano, Milan, Italy.
  • Dall'Olio FG; Department of Oncology, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy.
  • Landi L; Onco-Hematology Department, S Maria Delle Croci Hospital Ravenna, Italy.
  • Pizzutilo EG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy; Department of Oncology and Hemato-Oncology, Università Degli Studi di Milano, Milan, Italy.
  • Bartoli G; Pneumologia Oncologica, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
  • Baldessari C; Division of Medical Oncology, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy.
  • Novello S; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.
  • Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Università Cattolica Del Sacro Cuore, Rome, Italy.
  • Cortinovis DL; Oncology Unit, Ospedale S. Gerardo, Monza, Italy.
  • Rossi G; Pathology Unit, S. Maria Delle Croci Hospital, Ravenna, Italy.
  • Rossi A; Division of Medical Oncology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.
  • Banna GL; United Lincolnshire Hospitals NHS Trust, Lincoln, UK.
  • Camisa R; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Di Maio M; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Torino, Italy.
  • Tiseo M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Eur J Cancer ; 130: 155-167, 2020 05.
Article in En | MEDLINE | ID: mdl-32220780
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2020 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2020 Document type: Article Country of publication: Reino Unido